AYTU BIOPHARMA, INC Payments for (Proceeds from) Long-term Investments
AYTU BIOPHARMA, INC (AYTU) reported Payments for (Proceeds from) Long-term Investments of -$1.07 million for the 12-month period ending 2017-06-30, per its 10-K filed 2017-08-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForProceedsFromLongtermInvestments · last filed 2017-08-31
- AYTU BIOPHARMA, INC payments for (proceeds from) long-term investments for fiscal 2017 was -$1.07M, a 153.24% decline from fiscal 2016.
- AYTU BIOPHARMA, INC payments for (proceeds from) long-term investments for fiscal 2016 was $2.01M.
| Period end | Payments for (Proceeds from) Long-term Investments 12 month |
|---|---|
| 2017-06-30 | -$1.07M 10-K · filed 2017-08-31 |
| 2016-06-30 | $2.01M 10-K · filed 2017-08-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |